Carisma TherapeuticsCARM
13F holders, Q2 2025 (June 30)36holders −1
5new positions
6sold out
1famous investor
$0.39avg. 13F price*
At the end of Q2 2025, 36 institutions reported holding Carisma Therapeutics Inc. (CARM) in their 13F filings, down 1 from Q1 2025. 5 opened new positions and 6 sold out. The largest holders were Merck & Co., Inc. ($577K), AJU IB Investment Co., Ltd. ($281K) and Vanguard Group Inc. ($137K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Carisma Therapeutics Inc.
- CUSIP
- 14216R101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $88K |
| Exits | 6 | $81K |
All 13F filers, Q1 2025 → Q2 2025: 339,582 shares bought and 1,932,767 shares sold, net −1,593,185 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Merck & Co., Inc. | 0.27% | No change | 1,473,240 | $577K |
| AJU IB Investment Co., Ltd. | 0.31% | No change | 718,332 | $281K |
| Vanguard Group Inc. | 0.00% | Reduce -74.9% | 350,324 | $137K |
| BlackRock, Inc. | 0.00% | Reduce -17.2% | 336,789 | $132K |
| Renaissance Technologies | 0.00% | Add +29.8% | 329,286 | $129K |
| Geode Capital Management, LLC | 0.00% | Add +2.5% | 250,495 | $98K |
| Jane Street Group, LLC | 0.00% | New | 150,810 | $59K |
| State Street Corp. | 0.00% | No change | 85,106 | $33K |
| Northern Trust Corp. | 0.00% | No change | 55,039 | $22K |
| GTS Securities LLC | 0.00% | New | 50,118 | $20K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 30,988 | $12K |
| Empowered Funds, LLC | 0.00% | No change | 30,988 | $12K |
| Blodgett Wealth Advisors, LLC | 0.01% | No change | 24,001 | $9K |
| UBS Group AG | 0.00% | Add +618.4% | 22,105 | $9K |
| Two Sigma Securities, LLC | 0.00% | Add +54.6% | 17,952 | $7K |
| Dynamic Financial Group | 0.01% | No change | 15,350 | $6K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,026 | $5K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 18,404 | $4K |
| Morgan Stanley | 0.00% | Reduce -44.0% | 3,185 | $1K |
| Group One Trading LLC | 0.00% | No change | 2,230 | $873 |
| Bank of America Corp. | 0.00% | Reduce -81.7% | 1,335 | $522 |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.9% | 921 | $361 |
| Bank & Trust Co | 0.00% | No change | 525 | $206 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 535 | $190 |
| BNP Paribas Financial Markets | 0.00% | No change | 347 | $136 |
| IFP Advisors, Inc | 0.00% | No change | 206 | $81 |
| ORG Partners LLC | 0.00% | No change | 200 | $80 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 150 | $59 |
| Osaic Holdings, Inc. | 0.00% | No change | 142 | $55 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.8% | 132 | $52 |
| Barclays PLC | 0.00% | Reduce -100.0% | 100 | $39 |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 100 | $39 |
| Raymond James Financial Inc. | 0.00% | New | 75 | $29 |
| National Bank of Canada | 0.00% | No change | 50 | $20 |
| Harbour Investments, Inc. | 0.00% | No change | 37 | $14 |
| Jones Financial Companies LLLP | 0.00% | No change | 16 | $6 |
"% of holder's portfolio" is CARM's weight in each manager's 13F, not the share of Carisma Therapeutics Inc. the manager owns.